These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 17802695

  • 1. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A, Enomoto S, Kawahito H, Kurata H, Nakahara Y, Nakamura T.
    J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
    [Abstract] [Full Text] [Related]

  • 2. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F.
    J Am Coll Cardiol; 2008 Aug 19; 52(8):599-604. PubMed ID: 18702961
    [Abstract] [Full Text] [Related]

  • 3. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P, Pang D, Nykamp D, Knowlton G, Jia H.
    Ann Pharmacother; 2007 Jan 19; 41(1):46-50. PubMed ID: 17190844
    [Abstract] [Full Text] [Related]

  • 4. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O.
    Am Heart J; 2007 Sep 19; 154(3):539-44. PubMed ID: 17719303
    [Abstract] [Full Text] [Related]

  • 5. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention.
    Ochoa A, Pellizzon G, Addala S, Grines C, Isayenko Y, Boura J, Rempinski D, O'Neill W, Kahn J.
    J Interv Cardiol; 2004 Jun 19; 17(3):159-65. PubMed ID: 15209578
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A, Maioli M, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Manzone C, Amato M, Bellandi F.
    Am J Cardiol; 2010 Feb 01; 105(3):288-92. PubMed ID: 20102936
    [Abstract] [Full Text] [Related]

  • 7. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
    Baskurt M, Okcun B, Abaci O, Dogan GM, Kilickesmez K, Ozkan AA, Ersanli M, Gurmen T.
    Eur J Clin Invest; 2009 Sep 01; 39(9):793-9. PubMed ID: 19500141
    [Abstract] [Full Text] [Related]

  • 8. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
    Lee SW, Kim WJ, Kim YH, Park SW, Park DW, Yun SC, Lee JY, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Suh J, Cho YH, Lee NH, Cheong SS, Yoo SY, Lee BK, Lee SG, Hyon MS, Shin WY, Lee SW, Jang JS, Park SJ.
    Am J Cardiol; 2011 May 15; 107(10):1447-52. PubMed ID: 21420063
    [Abstract] [Full Text] [Related]

  • 9. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R.
    Minerva Cardioangiol; 2010 Feb 15; 58(1):35-40. PubMed ID: 20145594
    [Abstract] [Full Text] [Related]

  • 10. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.
    Int J Cardiol; 2010 Feb 04; 138(3):239-45. PubMed ID: 18793808
    [Abstract] [Full Text] [Related]

  • 11. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M.
    Am J Cardiol; 2007 Sep 01; 100(5):781-6. PubMed ID: 17719320
    [Abstract] [Full Text] [Related]

  • 12. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P, Chen Z, Popovtzer M.
    Ren Fail; 2009 Sep 01; 31(2):118-23. PubMed ID: 19212908
    [Abstract] [Full Text] [Related]

  • 13. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.
    Am Heart J; 2003 Dec 01; 146(6):E23. PubMed ID: 14661012
    [Abstract] [Full Text] [Related]

  • 14. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, Piccaluga E, Danna P, Scorza D.
    Nephrol Dial Transplant; 2009 Oct 01; 24(10):3103-7. PubMed ID: 19549691
    [Abstract] [Full Text] [Related]

  • 15. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study.
    Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, Banerjee D, Kaski JC, Cubero J, Cruz JM.
    J Am Coll Cardiol; 2007 Mar 27; 49(12):1283-8. PubMed ID: 17394959
    [Abstract] [Full Text] [Related]

  • 16. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F.
    Eur Rev Med Pharmacol Sci; 2013 Feb 27; 17 Suppl 1():13-21. PubMed ID: 23436661
    [Abstract] [Full Text] [Related]

  • 17. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Goldenberg I, Shechter M, Matetzky S, Jonas M, Adam M, Pres H, Elian D, Agranat O, Schwammenthal E, Guetta V.
    Eur Heart J; 2004 Feb 27; 25(3):212-8. PubMed ID: 14972421
    [Abstract] [Full Text] [Related]

  • 18. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.
    Am Heart J; 2009 Mar 27; 157(3):576-83. PubMed ID: 19249432
    [Abstract] [Full Text] [Related]

  • 19. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
    Coyle LC, Rodriguez A, Jeschke RE, Simon-Lee A, Abbott KC, Taylor AJ.
    Am Heart J; 2006 May 27; 151(5):1032.e9-12. PubMed ID: 16644332
    [Abstract] [Full Text] [Related]

  • 20. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S, Pornratanarangsi S.
    J Med Assoc Thai; 2010 Jan 27; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.